Human–mouse comparison of the multistage nature of radiation carcinogenesis in a mathematical model

Tatsuhiko Imaoka,Satoshi Tanaka,Masanori Tomita,Kazutaka Doi,Megumi Sasatani,Keiji Suzuki,Yutaka Yamada,Shizuko Kakinuma,Michiaki Kai
DOI: https://doi.org/10.1002/ijc.34987
2024-05-01
International Journal of Cancer
Abstract:What's new? Although mouse models are commonly used to assess the carcinogenic effects of environmental agents, challenges remain in the extrapolation of results to humans. In this study, a mathematical model of multistage carcinogenesis was employed to analyze existing radiation‐related cancer mortality data from Japanese atomic bomb survivors and lifespan mouse experiments. Analyses show that radiation exposure chronologically shifts the age‐related increase in cancer risk forward. Time shift per dose was ~100‐fold greater in humans, which was explained by the ~100‐fold interspecies difference in somatic mutation rates. The findings could help improve the use of experimental evidence for risk prediction in humans. Mouse models are vital for assessing risk from environmental carcinogens, including ionizing radiation, yet the interspecies difference in the dose response precludes direct application of experimental evidence to humans. Herein, we take a mathematical approach to delineate the mechanism underlying the human–mouse difference in radiation‐related cancer risk. We used a multistage carcinogenesis model assuming a mutational action of radiation to analyze previous data on cancer mortality in the Japanese atomic bomb survivors and in lifespan mouse experiments. Theoretically, the model predicted that exposure will chronologically shift the age‐related increase in cancer risk forward by a period corresponding to the time in which the spontaneous mutational process generates the same mutational burden as that the exposure generates. This model appropriately fitted both human and mouse data and suggested a linear dose response for the time shift. The effect per dose decreased with increasing age at exposure similarly between humans and mice on a per‐lifespan basis (0.72‐ and 0.71‐fold, respectively, for every tenth lifetime). The time shift per dose was larger by two orders of magnitude in humans (7.8 and 0.046 years per Gy for humans and mice, respectively, when exposed at ~35% of their lifetime). The difference was mostly explained by the two orders of magnitude difference in spontaneous somatic mutation rates between the species plus the species‐independent radiation‐induced mutation rate. Thus, the findings delineate the mechanism underlying the interspecies difference in radiation‐associated cancer mortality and may lead to the use of experimental evidence for risk prediction in humans.
oncology
What problem does this paper attempt to address?